Atrial fibrillation (AFib) and supraventricular tachycardia (SVT) both cause a fast heartbeat that starts in the upper chambers of the heart, but they feel different, behave differently, and carry different risks. The key distinction: AFib produces an irregular, chaotic rhythm, while SVT typically causes a fast but steady one. Understanding which you have matters because AFib significantly raises stroke risk, while most forms of SVT do not.
To add a layer of complexity, AFib is technically a subtype of SVT. “Supraventricular tachycardia” is an umbrella term for any fast heart rhythm originating above the lower chambers. But in everyday medical conversation, when doctors say “SVT,” they almost always mean the regular, sudden-onset types, not AFib. This article follows that common usage.
How the Electrical Problem Differs
In AFib, the heart’s upper chambers receive a storm of disorganized electrical signals, firing more than 300 times per minute. These chaotic impulses cause the upper chambers to quiver instead of contracting with a coordinated squeeze. Only some of those signals make it through to the lower chambers, which is why the heartbeat ends up both fast and irregular.
In the most common forms of SVT, the problem is a short circuit rather than electrical chaos. About 50 to 60 percent of SVT cases involve a loop of electrical activity circling within the heart’s central junction box (a type called AVNRT). Another 20 to 30 percent involve an extra electrical wire connecting the upper and lower chambers that shouldn’t be there (called AVRT, the type seen in Wolff-Parkinson-White syndrome). Because the signal travels in a predictable loop, the resulting heartbeat is fast but regular.
What Each One Feels Like
SVT episodes tend to start and stop abruptly. One moment your heart is beating normally, and the next it’s racing at 130 to 250 beats per minute. Episodes can last a few minutes to a few days, then end just as suddenly as they began. Many people describe it as a light switch flipping on and off. The rapid but steady pounding is the hallmark sensation.
AFib feels different. The heart rate is usually somewhat lower, typically 90 to 160 beats per minute, but what stands out is the irregularity. Rather than a steady fast drumbeat, you may feel fluttering, skipping, or a heart that seems to stumble over itself. AFib episodes can also come and go, but they tend to become more frequent and longer-lasting over time. Some people eventually stay in AFib continuously.
Both conditions can cause lightheadedness, shortness of breath, chest discomfort, and fatigue. But the pattern of the heartbeat itself, steady versus erratic, is the most reliable clue to which one you’re experiencing.
How Doctors Tell Them Apart
An electrocardiogram (ECG) is the definitive tool. In AFib, the tracing shows no organized electrical activity before each heartbeat and the spacing between beats is completely irregular. In SVT, the tracing shows a fast but regular rhythm with evenly spaced beats.
The challenge is catching the rhythm while it’s happening. If your episodes are brief or infrequent, a standard ECG taken at a doctor’s office may look completely normal. A 24-hour Holter monitor is commonly used, but its sensitivity for catching intermittent episodes is limited. Longer-term monitoring, such as a 14-day adhesive patch monitor, picks up clinically important rhythms that shorter recordings miss entirely. For very infrequent episodes, an implantable loop recorder can monitor your heart continuously for years.
Stroke Risk Is the Critical Difference
This is where the distinction between AFib and SVT matters most. Because AFib causes the upper chambers to quiver instead of contracting fully, blood can pool and form clots. Those clots can travel to the brain and cause a stroke. This risk is significant enough that most people with AFib need blood-thinning medication, and the decision about which patients need it is one of the most important parts of AFib management.
SVT carries a much lower stroke risk. In one study of over 1,300 patients with SVT, unexplained stroke was found in only 2.8 percent, and the strongest predictors of stroke in that group were older age and a history of developing AFib alongside their SVT. SVT on its own, without AFib, does not typically require blood thinners.
How SVT Episodes Can Be Stopped at Home
One practical difference between SVT and AFib is that many SVT episodes can be interrupted with simple physical techniques called vagal maneuvers. These work by stimulating the vagus nerve, which slows electrical conduction through the heart’s central junction and can break the short circuit.
The most common technique is the Valsalva maneuver: lying flat on your back and bearing down hard, as if blowing into a blocked straw, for about 15 seconds. Studies show success rates ranging from about 19 to 54 percent depending on technique and setting. Lying down rather than sitting appears to improve the odds. Other approaches include splashing ice-cold water on your face or briefly holding your breath.
These maneuvers generally do not work for AFib because there is no single short circuit to interrupt. AFib’s chaotic electrical activity doesn’t depend on the same looping pathway that vagal stimulation can block.
Long-Term Treatment
Treatment strategies diverge significantly between the two conditions.
For AFib, there are two broad approaches. Rate control aims to keep the heart from beating too fast during episodes using medications that slow conduction to the lower chambers, such as beta-blockers or calcium channel blockers. Rhythm control aims to restore and maintain a normal heart rhythm using antiarrhythmic medications or catheter ablation. In ablation for AFib, the goal is to electrically isolate the pulmonary veins, which are the most common source of the erratic signals. Newer techniques including cryoballoon (freezing) and pulsed field ablation have shown effectiveness comparable to traditional heat-based methods.
For SVT, catheter ablation targets the specific short circuit causing the problem, whether that’s the dual pathway in AVNRT or the extra connection in AVRT. Because the target is a discrete, identifiable circuit rather than a diffuse area, ablation success rates for SVT are generally higher than for AFib, often exceeding 95 percent with a very low risk of major complications. Many people with SVT are effectively cured by a single procedure. Medications such as beta-blockers can also be used for people who prefer not to have ablation or whose episodes are infrequent and well-tolerated.
Who Gets Each Condition
AFib becomes increasingly common with age. It affects roughly 1 to 2 percent of the general population, with prevalence climbing steeply after age 60. Risk factors include high blood pressure, obesity, sleep apnea, heart valve disease, and heavy alcohol use. AFib tends to be a progressive condition, meaning episodes often become more frequent and longer over time.
SVT can occur at any age, including in children and young adults with otherwise healthy hearts. AVNRT, the most common subtype, is more frequent in women. Many people with SVT have no underlying heart disease at all. Unlike AFib, SVT does not typically worsen over the years, though episodes may become more bothersome and some people choose ablation for quality of life rather than medical necessity.